Pic: Godji10 / iStock / Getty Images Plus via Getty Images
Check up: Who’s in your coronavirus portfolio?
Health & Biotech
share
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 137-odd small cap health stocks, 68 saw their share prices fall, 55 improved and 14 were flat.
| Code | Name | Price (Feb 19) | 2 week return % | 1 year return % | Market cap |
|---|---|---|---|---|---|
| HCT | HOLISTA COLLTECH LTD | 0.210 | 147 | 279 | $57,909,660 |
| ZNO | ZOONO GROUP LTD | 1.790 | 109 | 1848 | $308,661,024 |
| UCM | USCOM LTD | 0.335 | 94 | 169 | $52,320,752 |
| RAC | RACE ONCOLOGY LTD | 0.400 | 67 | 388 | $44,749,408 |
| OVN | OVENTUS MEDICAL LTD | 0.550 | 51 | 103 | $73,096,640 |
| MX1 | MICRO-X LTD | 0.185 | 50 | -15 | $48,753,988 |
| RCE | RECCE PHARMACEUTICALS LTD | 0.518 | 44 | 215 | $69,817,312 |
| MEM | MEMPHASYS LTD | 0.063 | 34 | 156 | $47,500,356 |
| BIT | BIOTRON LTD | 0.120 | 34 | 28 | $80,722,264 |
| ATX | AMPLIA THERAPEUTICS LTD | 0.089 | 32 | -35 | $6,247,540 |
| PIQ | PROTEOMICS INTERNATIONAL LAB | 0.350 | 31 | 0 | $31,239,498 |
| ANP | ANTISENSE THERAPEUTICS LTD | 0.087 | 28 | 129 | $38,125,252 |
| CMP | COMPUMEDICS LTD | 0.863 | 28 | 157 | $155,017,584 |
| NOX | NOXOPHARM LTD | 0.265 | 27 | -30 | $37,016,052 |
| S66 | STAR COMBO PHARMA LTD | 0.565 | 23 | -7 | $48,893,180 |
| AZV | AZURE HEALTHCARE LTD | 0.115 | 22 | 97 | $31,260,784 |
| IMM | IMMUTEP LTD | 0.445 | 22 | 27 | $152,736,064 |
| SDI | SDI LTD | 1.015 | 16 | 26 | $118,865,528 |
| BD1 | BARD1 LIFE SCIENCES LTD | 0.038 | 16 | 96 | $50,585,844 |
| TLX | TELIX PHARMACEUTICALS LTD | 1.640 | 15 | 135 | $416,916,736 |
| AHX | APIAM ANIMAL HEALTH LTD | 0.530 | 15 | 19 | $62,577,576 |
| AVH | AVITA MEDICAL LTD | 0.838 | 15 | 482 | $1,725,741,568 |
| CAJ | CAPITOL HEALTH LTD | 0.278 | 12 | 17 | $215,151,840 |
| BWX | BWX LTD | 4.465 | 12 | 186 | $562,851,968 |
| ALC | ALCIDION GROUP LTD | 0.205 | 10 | 450 | $217,952,688 |
| SVA | SIMAVITA LTD-CDI | 0.023 | 10 | 35 | $9,608,897 |
| IMU | IMUGENE LTD | 0.034 | 9 | 106 | $154,908,976 |
| PBP | PROBIOTEC LTD | 2.400 | 9 | 63 | $180,964,864 |
| CGS | COGSTATE LTD | 0.490 | 9 | 10 | $82,575,616 |
| ICS | ICSGLOBAL LTD | 1.995 | 9 | 131 | $21,155,018 |
| DVL | DORSAVI LTD | 0.021 | 8 | -39 | $6,248,543 |
| ADO | ANTEOTECH LTD | 0.030 | 7 | 69 | $43,509,128 |
| PNV | POLYNOVO LTD | 3.220 | 7 | 345 | $2,042,762,112 |
| PYC | PYC THERAPEUTICS LTD | 0.064 | 7 | 156 | $187,611,392 |
| HLA | HEALTHIA LTD | 1.305 | 7 | 27 | $82,260,224 |
| PSQ | PACIFIC SMILES GROUP LTD | 1.860 | 6 | 41 | $284,987,616 |
| PAB | PATRYS LTD | 0.017 | 6 | -18 | $19,306,626 |
| VBS | VECTUS BIOSYSTEMS LTD | 0.580 | 5 | 66 | $13,719,793 |
| EHH | EAGLE HEALTH HOLDINGS LTD | 0.120 | 4 | -53 | $42,133,992 |
| SKN | SKIN ELEMENTS LTD | 0.014 | 4 | -18 | $2,934,004 |
| PAL | PALLA PHARMA LTD | 0.845 | 4 | -14 | $106,426,040 |
| DXB | DIMERIX LTD | 0.145 | 4 | 71 | $26,321,374 |
| IBX | IMAGION BIOSYSTEMS LTD | 0.030 | 3 | 3 | $15,338,466 |
| M7T | MACH7 TECHNOLOGIES LTD | 0.840 | 3 | 328 | $156,318,912 |
| ACR | ACRUX LTD | 0.175 | 3 | 0 | $29,289,674 |
| LSH | LIFESPOT HEALTH LTD | 0.035 | 3 | -50 | $2,714,904 |
| BLT | BENITEC BIOPHARMA LTD | 0.036 | 3 | -70 | $11,566,333 |
| JHC | JAPARA HEALTHCARE LTD | 0.950 | 3 | -27 | $259,229,904 |
| MVF | MONASH IVF GROUP LTD | 0.995 | 3 | 14 | $238,143,744 |
| SUD | SUDA PHARMACEUTICALS LTD | 0.055 | 2 | -54 | $7,823,992 |
| ELX | ELLEX MEDICAL LASERS LTD | 0.830 | 2 | 38 | $119,188,944 |
| IMC | IMMURON LTD | 0.135 | 2 | -47 | $24,810,576 |
| SOM | SOMNOMED LTD | 3.270 | 1 | 104 | $208,509,840 |
| RSH | RESPIRI LTD | 0.081 | 1 | 2 | $47,281,940 |
| ONT | 1300 SMILES LTD | 6.350 | 1 | 7 | $150,357,744 |
| NVL | NATIONAL VETERINARY CARE LTD | 3.680 | 0 | 92 | $246,811,920 |
| RAP | RESAPP HEALTH LTD | 0.240 | 0 | 161 | $167,101,328 |
| PAA | PHARMAUST LTD | 0.105 | 0 | 213 | $31,712,210 |
| FTT | FACTOR THERAPEUTICS LTD | 0.003 | 0 | -17 | $2,607,089 |
| MDR | MEDADVISOR LTD | 0.500 | 0 | 93 | $122,970,536 |
| ALT | ANALYTICA LTD | 0.003 | 0 | -40 | $10,558,837 |
| LCT | LIVING CELL TECHNOLOGIES LTD | 0.019 | 0 | -51 | $10,857,379 |
| BPH | BPH ENERGY LTD | 0.001 | 0 | 0 | $3,341,463 |
| VTI | VISIONEERING TECH-CDI | 0.039 | 0 | -63 | $18,166,270 |
| GTG | GENETIC TECHNOLOGIES LTD | 0.010 | 0 | 34 | $40,631,340 |
| FFC | FARMAFORCE LTD | 0.090 | 0 | 0 | $11,589,388 |
| NYR | NYRADA INC-CDI | 0.205 | 0 | $22,423,664 | |
| OCC | ORTHOCELL LTD | 0.475 | 0 | 288 | $89,412,064 |
| MVP | MEDICAL DEVELOPMENTS INTERNA | 10.390 | 0 | 184 | $711,182,784 |
| THC | THC GLOBAL GROUP LTD | 0.370 | -1 | -32 | $52,084,732 |
| AC8 | AUSCANN GROUP HOLDINGS LTD | 0.305 | -2 | -34 | $95,114,208 |
| 1ST | 1ST GROUP LTD | 0.057 | -2 | 97 | $24,203,164 |
| CYC | CYCLOPHARM LTD | 1.100 | -2 | 1 | $86,062,240 |
| NEU | NEUREN PHARMACEUTICALS LTD | 2.600 | -2 | 113 | $283,717,568 |
| OPT | OPTHEA LTD | 3.480 | -2 | 361 | $893,603,776 |
| BOT | BOTANIX PHARMACEUTICALS LTD | 0.089 | -3 | -9 | $88,515,520 |
| LBT | LBT INNOVATIONS LTD | 0.140 | -3 | 105 | $35,330,968 |
| ANR | ANATARA LIFESCIENCES LTD | 0.240 | -4 | -41 | $12,962,606 |
| PXS | PHARMAXIS LTD | 0.115 | -4 | -56 | $45,393,972 |
| GSS | GENETIC SIGNATURES LTD | 1.140 | -4 | 22 | $163,673,456 |
| OSX | OSTEOPORE LTD | 0.600 | -5 | $59,725,996 | |
| CDY | CELLMID LTD | 0.185 | -5 | -12 | $17,870,420 |
| UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.175 | -5 | -27 | $31,053,932 |
| OSL | ONCOSIL MEDICAL LTD | 0.165 | -6 | 3 | $107,220,496 |
| CTE | CRYOSITE LTD | 0.050 | -6 | 22 | $2,342,978 |
| PTX | PRESCIENT THERAPEUTICS LTD | 0.053 | -6 | -28 | $19,713,032 |
| NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.165 | -6 | -18 | $12,933,456 |
| OIL | OPTISCAN IMAGING LTD | 0.033 | -6 | -42 | $15,766,700 |
| CYP | CYNATA THERAPEUTICS LTD | 1.050 | -6 | -33 | $107,653,968 |
| CAN | CANN GROUP LTD | 1.090 | -6 | -37 | $158,088,496 |
| IHL | IMPRESSION HEALTHCARE LTD | 0.061 | -6 | 244 | $44,479,788 |
| MDC | MEDLAB CLINICAL LTD | 0.305 | -6 | -22 | $71,132,656 |
| VLS | VITA LIFE SCIENCES LTD | 0.590 | -6 | -16 | $32,203,742 |
| GLH | GLOBAL HEALTH LTD | 0.140 | -7 | -7 | $5,893,765 |
| VHT | VOLPARA HEALTH TECHNOLOGIES | 1.680 | -7 | 66 | $364,594,368 |
| TD1 | TALI DIGITAL LTD | 0.041 | -7 | 60 | $29,972,208 |
| CDX | CARDIEX LTD | 0.026 | -7 | -62 | $18,830,232 |
| BNO | BIONOMICS LTD | 0.062 | -8 | -63 | $33,225,838 |
| RHY | RHYTHM BIOSCIENCES LTD | 0.092 | -8 | -32 | $9,269,000 |
| KZA | KAZIA THERAPEUTICS LTD | 0.575 | -8 | 25 | $41,495,836 |
| MMJ | MMJ GROUP HOLDINGS LTD | 0.110 | -8 | -56 | $24,683,888 |
| RNO | RHINOMED LTD | 0.160 | -9 | 0 | $27,072,962 |
| ACW | ACTINOGEN MEDICAL LTD | 0.031 | -9 | -43 | $34,603,172 |
| IVX | INVION LTD | 0.010 | -9 | -41 | $55,006,064 |
| ESE | ESENSE-LAB LTD-CDI | 0.010 | -9 | -57 | $1,900,769 |
| PAR | PARADIGM BIOPHARMACEUTICALS | 3.870 | -9 | 252 | $781,365,696 |
| IDT | IDT AUSTRALIA LTD | 0.135 | -10 | -18 | $31,988,676 |
| ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.135 | -10 | -72 | $23,383,550 |
| ZLD | ZELIRA THERAPEUTICS LTD | 0.062 | -11 | 5 | $50,717,708 |
| MEB | MEDIBIO LTD | 0.008 | -11 | -64 | $7,961,041 |
| ADR | ADHERIUM LTD | 0.031 | -11 | 45 | $15,905,413 |
| RHT | RESONANCE HEALTH LTD | 0.195 | -11 | 186 | $86,176,784 |
| RGS | REGENEUS LTD | 0.063 | -11 | -50 | $17,502,974 |
| SDX | SIENNA CANCER DIAGNOSTICS LT | 0.038 | -12 | -41 | $15,015,048 |
| PGC | PARAGON CARE LTD | 0.275 | -12 | -37 | $96,297,312 |
| IPD | IMPEDIMED LTD | 0.105 | -13 | -56 | $53,660,176 |
| AVE | AVECHO BIOTECHNOLOGY LTD | 0.004 | -13 | -13 | $5,521,101 |
| NTI | NEUROTECH INTERNATIONAL LTD | 0.007 | -13 | -75 | $950,207 |
| APH | AUSTRALIAN PRIMARY HEMP LTD | 0.135 | -13 | -25 | $9,386,568 |
| AGH | ALTHEA GROUP HOLDINGS LTD | 0.365 | -14 | -9 | $85,158,152 |
| ATH | ALTERITY THERAPEUTICS LTD | 0.017 | -15 | -58 | $15,170,289 |
| JHL | JAYEX HEALTHCARE LTD | 0.022 | -15 | -15 | $3,797,487 |
| MXC | MGC PHARMACEUTICALS LTD | 0.028 | -16 | -31 | $37,020,316 |
| SIL | SMILES INCLUSIVE LTD | 0.040 | -17 | -85 | $5,329,827 |
| 1AD | ADALTA LTD | 0.083 | -17 | -64 | $13,607,486 |
| CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.130 | -17 | -4 | $11,175,000 |
| NXS | NEXT SCIENCE LTD | 2.000 | -18 | $363,721,920 | |
| NC6 | NANOLLOSE LTD | 0.059 | -19 | -26 | $4,425,000 |
| GMV | G MEDICAL INNOVATION HOLDING | 0.085 | -20 | -71 | $36,621,456 |
| PCK | PAINCHEK LTD | 0.120 | -21 | 156 | $119,085,080 |
| SCU | STEMCELL UNITED LTD | 0.014 | -22 | -30 | $8,982,517 |
| CPH | CRESO PHARMA LTD | 0.120 | -23 | -68 | $24,937,124 |
| BXN | BIOXYNE LTD | 0.013 | -24 | -50 | $8,321,890 |
| EXL | ELIXINOL GLOBAL LTD | 0.565 | -26 | -85 | $76,531,232 |
| AMT | ALLEGRA ORTHOPAEDICS LTD | 0.110 | -30 | -30 | $13,938,267 |
| TDL | TBG DIAGNOSTICS LTD | 0.022 | -31 | -48 | $4,786,921 |
| OSP | OSPREY MEDICAL INC-CDI | 0.018 | -32 | -84 | $7,340,556 |
Every opportunistic player has been jumping on the COVID-19 play, which has seen share prices rocket and companies blatantly bandwagon like Food Revolution (ASX:FOD), which says it has cleared a factory floor to cater to a demand for hand sanitiser which — if you believe the Chinese — only has a few more weeks to run.
But had you been reading the tea leaves in December, in the style of Axe from Billions, maybe you’d have collected a coronavirus portfolio something like this, and made a big pile of money.
The top three winners from the last fortnight are of course the leaders of any Chinese disease portfolio — at least in terms of market returns.
The first two sell hand sanitiser and have been successfully convincing investors of shortages in their respective markets, and the third sells blood flow monitoring units, which China is now recommending to be used on critical COVID-19 cases.
Micro-X (ASX:MX1) is up there, after saying China wants more of its mini x-rays to look inside victims’ chests, and Aeris Environmental (ASX:AEI) — not a health company — is also a COVID-19 beneficiary after the Singapore National Environmental Agency (NEA) said its hospital-grade disinfectant was added to a list of approved general products for virus disinfection.
The last is Biotron (ASX:BIT), which is not a company shy of the big issues. It hit the bit time in late 2018 with positive clinical trial data around an HIV cure, but hasn’t had much news to share with investors since.
But at the start of February the company said it had been tinkering with its compounds and coronavirus generally (a family of viruses that at its weakest causes the common cold).
In the lab, Biotron can kill 90-100 per cent of a coronavirus-infected cell.
The company says it’s focused on testing a select few compounds, but it’ll no doubt take more than a promising compound to get into the few labs in the world that have access to the Chinese form of the virus.
Investors would be wise to remember too that all kinds of things have been shown to work in the lab, from vitamin C killing cancer cells to bleach.
